Evonik Industries (FRA:EVK) has been given a €29.60 ($34.42) price target by Goldman Sachs Group in a report released on Monday, Borsen Zeitung reports. The firm currently has a “buy” rating on the stock. Goldman Sachs Group’s target price suggests a potential upside of 12.38% from the company’s current price.
EVK has been the subject of several other research reports. Credit Suisse Group set a €25.00 ($29.07) price target on shares of Evonik Industries and gave the stock a “neutral” rating in a report on Tuesday, November 5th. UBS Group set a €20.00 ($23.26) price target on shares of Evonik Industries and gave the stock a “sell” rating in a report on Tuesday, November 5th. Baader Bank set a €29.00 ($33.72) price target on shares of Evonik Industries and gave the stock a “buy” rating in a report on Tuesday, November 5th. Warburg Research set a €36.00 ($41.86) price objective on shares of Evonik Industries and gave the company a “buy” rating in a research note on Tuesday, November 5th. Finally, Berenberg Bank set a €30.00 ($34.88) price objective on shares of Evonik Industries and gave the company a “buy” rating in a research note on Wednesday, November 6th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and ten have issued a buy rating to the company. Evonik Industries currently has an average rating of “Hold” and a consensus price target of €28.78 ($33.47).
Evonik Industries stock traded up €0.12 ($0.14) during mid-day trading on Monday, hitting €26.34 ($30.63). 946,424 shares of the stock were exchanged. Evonik Industries has a 12 month low of €26.78 ($31.14) and a 12 month high of €32.97 ($38.34). The firm’s fifty day simple moving average is €23.31 and its two-hundred day simple moving average is €24.31.
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Read More: Backdoor Roth IRA Conversion and Strategy
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.